<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>28(11)</volume><submitter>Gupta D</submitter><pubmed_abstract>LisH-domain-containing proteins are involved in diverse cellular processes and disease mechanisms, yet their functional interaction landscape remains poorly characterized. Here, we employed a proteomics-based strategy to systematically map the interaction network of 27 LisH-domain-containing proteins, uncovering 1,410 high-confidence interactions-90% of which are previously unreported. This network reveals unanticipated roles for LisH proteins in cellular regulation and uncovers links to human disease, including cancer-associated interactions. Focusing on Lis1, a cytoplasmic dynein regulator, we identify the RBR-E3 ubiquitin ligase ARIH2 as a key functional interactor. We show that Lis1 promotes ARIH2 deneddylation via the COP9 signalosome (CSN), modulating its ubiquitin ligase activity. A</pubmed_abstract><journal>iScience</journal><pagination>113912</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12648486</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A LisH-domain protein interaction map reveals a Lis1-ARIH2-dynein regulatory axis.</pubmed_title><pmcid>PMC12648486</pmcid><pubmed_authors>Gupta D</pubmed_authors><pubmed_authors>Maddika S</pubmed_authors></additional><is_claimable>false</is_claimable><name>A LisH-domain protein interaction map reveals a Lis1-ARIH2-dynein regulatory axis.</name><description>LisH-domain-containing proteins are involved in diverse cellular processes and disease mechanisms, yet their functional interaction landscape remains poorly characterized. Here, we employed a proteomics-based strategy to systematically map the interaction network of 27 LisH-domain-containing proteins, uncovering 1,410 high-confidence interactions-90% of which are previously unreported. This network reveals unanticipated roles for LisH proteins in cellular regulation and uncovers links to human disease, including cancer-associated interactions. Focusing on Lis1, a cytoplasmic dynein regulator, we identify the RBR-E3 ubiquitin ligase ARIH2 as a key functional interactor. We show that Lis1 promotes ARIH2 deneddylation via the COP9 signalosome (CSN), modulating its ubiquitin ligase activity. A</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T18:49:43.792Z</modification><creation>2026-05-20T03:13:38.442Z</creation></dates><accession>S-EPMC12648486</accession><cross_references><pubmed>41312386</pubmed><doi>10.1016/j.isci.2025.113912</doi></cross_references></HashMap>